tiprankstipranks
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
India Market
AUROPHARMA
Aurobindo Pharma Ltd
RESEARCH TOOLSreports

Aurobindo Pharma Ltd (AUROPHARMA) Ratios

4 Followers

Aurobindo Pharma Ltd Ratios

IN:AUROPHARMA's free cash flow for Q2 2026 was ₹0.39. For the 2026 fiscal year, IN:AUROPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.17. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.85 1.85 1.98 1.87 2.22
Quick Ratio
 1.13 1.13 1.18 1.13 1.30
Cash Ratio
 0.57 0.56 0.28 0.38 0.51
Solvency Ratio
 0.29 0.29 0.30 0.23 0.39
Operating Cash Flow Ratio
 0.19 0.27 0.20 0.21 0.62
Short-Term Operating Cash Flow Coverage
 0.44 0.62 0.58 0.56 1.97
Net Current Asset Value
₹ 111.37B₹ 100.24B₹ 89.85B₹ 85.08B₹ 87.75B
Leverage Ratios
Debt-to-Assets Ratio
 0.15 0.17 0.15 0.13 0.10
Debt-to-Equity Ratio
 0.22 0.25 0.22 0.20 0.13
Debt-to-Capital Ratio
 0.18 0.20 0.18 0.16 0.12
Long-Term Debt-to-Capital Ratio
 0.03 0.05 0.07 0.02 0.01
Financial Leverage Ratio
 1.50 1.52 1.51 1.49 1.38
Debt Service Coverage Ratio
 0.78 0.71 1.02 0.67 1.38
Interest Coverage Ratio
 18.78 26.25 36.07 57.69 160.48
Debt to Market Cap
 0.10 0.12 0.10 0.16 0.07
Interest Debt Per Share
 141.10 149.61 118.40 92.62 56.78
Net Debt to EBITDA
 -0.16 <0.01 0.56 0.24 -0.20
Profitability Margins
Gross Profit Margin
47.48%57.50%55.22%53.16%55.45%
EBIT Margin
16.20%15.72%15.14%10.11%14.10%
EBITDA Margin
21.23%20.29%19.87%14.62%18.38%
Operating Profit Margin
22.69%37.83%36.03%32.61%33.28%
Pretax Profit Margin
15.54%15.97%15.10%10.51%14.38%
Net Profit Margin
10.51%10.99%10.94%7.75%11.29%
Continuous Operations Profit Margin
10.50%10.98%10.93%7.76%11.29%
Net Income Per EBT
67.62%68.81%72.44%73.78%78.52%
EBT Per EBIT
68.49%42.22%41.91%32.23%43.21%
Return on Assets (ROA)
6.64%7.00%7.04%4.83%7.81%
Return on Equity (ROE)
10.63%10.68%10.63%7.18%10.78%
Return on Capital Employed (ROCE)
20.32%34.19%31.79%28.54%30.30%
Return on Invested Capital (ROIC)
11.68%19.85%20.36%18.26%21.51%
Return on Tangible Assets
7.25%7.65%7.74%5.36%8.74%
Earnings Yield
4.48%5.27%4.86%6.35%6.76%
Efficiency Ratios
Receivables Turnover
 5.62 5.51 6.02 5.56 5.35
Payables Turnover
 3.67 3.22 2.92 3.01 3.87
Inventory Turnover
 1.56 1.28 1.32 1.37 1.38
Fixed Asset Turnover
 2.03 2.05 2.01 1.94 2.18
Asset Turnover
 0.63 0.64 0.64 0.62 0.69
Working Capital Turnover Ratio
 5.05 2.59 2.63 2.48 2.45
Cash Conversion Cycle
 199.90 238.31 211.11 211.06 237.70
Days of Sales Outstanding
 64.99 66.29 60.62 65.59 68.27
Days of Inventory Outstanding
 234.42 285.41 275.69 266.85 263.85
Days of Payables Outstanding
 99.50 113.39 125.20 121.38 94.41
Operating Cycle
 299.41 351.70 336.31 332.44 332.11
Cash Flow Ratios
Operating Cash Flow Per Share
 49.67 67.33 41.55 40.73 85.60
Free Cash Flow Per Share
 26.20 33.57 -19.23 -5.69 39.45
CapEx Per Share
 23.47 33.76 60.78 46.43 46.15
Free Cash Flow to Operating Cash Flow
 0.53 0.50 -0.46 -0.14 0.46
Dividend Paid and CapEx Coverage Ratio
 1.81 1.99 0.64 0.76 1.69
Capital Expenditure Coverage Ratio
 2.12 1.99 0.68 0.88 1.85
Operating Cash Flow Coverage Ratio
 0.37 0.47 0.37 0.45 1.53
Operating Cash Flow to Sales Ratio
 0.09 0.12 0.08 0.10 0.21
Free Cash Flow Yield
1.96%2.96%-1.73%-1.10%5.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 22.52 18.96 20.56 15.75 14.79
Price-to-Sales (P/S) Ratio
 2.37 2.08 2.25 1.22 1.67
Price-to-Book (P/B) Ratio
 2.24 2.02 2.19 1.13 1.59
Price-to-Free Cash Flow (P/FCF) Ratio
 51.60 33.78 -57.89 -90.99 16.95
Price-to-Operating Cash Flow Ratio
 27.22 16.84 26.80 12.72 7.81
Price-to-Earnings Growth (PEG) Ratio
 11.96 1.81 0.32 -0.58 -0.29
Price-to-Fair Value
 2.24 2.02 2.19 1.13 1.59
Enterprise Value Multiple
 10.99 10.28 11.88 8.60 8.88
Enterprise Value
 767.19B 661.34B 684.90B 312.47B 382.94B
EV to EBITDA
 10.89 10.28 11.88 8.60 8.88
EV to Sales
 2.31 2.08 2.36 1.26 1.63
EV to Free Cash Flow
 50.41 33.80 -60.77 -93.65 16.56
EV to Operating Cash Flow
 26.59 16.85 28.13 13.09 7.63
Tangible Book Value Per Share
 526.41 487.39 439.88 391.34 357.69
Shareholders’ Equity Per Share
 603.32 560.22 509.32 458.07 419.38
Tax and Other Ratios
Effective Tax Rate
 0.32 0.31 0.28 0.26 0.22
Revenue Per Share
 571.31 544.27 494.96 424.20 400.26
Net Income Per Share
 60.04 59.81 54.15 32.90 45.19
Tax Burden
 0.68 0.69 0.72 0.74 0.79
Interest Burden
 0.96 1.02 1.00 1.04 1.02
Research & Development to Revenue
 0.09 0.05 0.05 0.06 0.07
SG&A to Revenue
 0.17 0.14 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 0.00 0.00
Income Quality
 0.68 1.13 0.77 0.91 1.49
Currency in INR